Cyclin D1 as a Diagnostic Immunomarker for Endometrial Stromal Sarcoma With YWHAE-FAM22 RearrangementCheng‐Han Lee, Marisa R. Nucci, Alayne Brunner et al.|The American Journal of Surgical Pathology|2012Cited by 199
Prognostic gene expression signature for high-grade serous ovarian cancerJoshua Millstein, Scott D. Brown, Timothy Budden et al.|Annals of Oncology|2020Cited by 173
Validated biomarker assays confirm that <scp>ARID1A</scp> loss is confounded with <scp>MMR</scp> deficiency, <scp> CD8 <sup>+</sup> TIL </scp> infiltration, and provides no independent prognostic value in endometriosis‐associated ovarian carcinomasKarolin Heinze, Yurii B. Shvetsov, Tayyebeh M. Nazeran et al.|The Journal of Pathology|2021Cited by 42
Response: Re: Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast CancerTorsten O. Nielsen, Matthew J. Ellis, Maggie C.U. Cheang et al.|JNCI Journal of the National Cancer Institute|2009Cited by 32
Intrinsic subtypes and benefit from postmastectomy radiotherapy in node-positive premenopausal breast cancer patients who received adjuvant chemotherapy – results from two independent randomized trialsTinne Laurberg, Maggie C.U. Cheang, Trine Tramm et al.|Acta Oncologica|2017Cited by 31